Trapped Ions Versus Photonic Chips: The Current Quantum Race
IonQ and Quantum Computing Inc. (QCi) occupy distinct positions in the race to scale functional quantum hardware. IonQ relies on trapped-ion technology, a method that uses individual atoms as qubits to perform calculations. This approach prioritizes stability and long-term coherence. Access to these systems remains primarily cloud-based through partnerships with major providers like Amazon Web Services.
Quantum Computing Inc. takes a different path. The company focuses on room-temperature quantum photonics. Unlike systems that require extreme cooling to near-absolute zero, QCi hardware uses light-based processing. Its business model leans heavily into public sector contracts, with 70% to 80% of revenue derived from government work. Both firms remain in a high-risk, capital-intensive phase where achieving a definitive, scalable advantage over classical supercomputers remains the main hurdle.
Financial Health and Operational Scale
IonQ’s 2025 financial results highlight a period of massive expansion and heavy spending. Revenue reached $130 million, a 202% jump from the prior year. However, the costs associated with infrastructure build-out resulted in a net loss of $510.4 million. The firm maintains a strong liquidity position, with a current ratio of 15.5x and no debt on its balance sheet. While operating losses remain deep, the triple-digit revenue growth points to rising commercial demand.
Quantum Computing Inc. operates at a smaller scale. Revenue for 2025 was $682,000, which is an 82.8% increase over the previous year. The company reported a net loss of $18.7 million for the same period. Because its workforce is significantly smaller than IonQ’s, the absolute dollar amount of its losses is lower. The company’s current ratio is 102.4x, indicating high liquidity despite its ongoing need for external funding to support continued research and development.
Industry Context and Strategic Outlook
Commercial adoption of quantum computing is in the early stages. The primary challenge for IonQ is scaling its hardware while navigating the integration risks of recent acquisitions like the July 2026 purchase of a chip foundry. Competition is fierce, with well-capitalized tech giants and sovereign-funded initiatives vying for the same market share. Integration of these new assets will be a key performance indicator in upcoming quarters.
For QCi, the path forward involves scaling production of its photonic chips. Reliance on third-party suppliers, particularly those in East Asia, presents supply chain vulnerabilities. The company is betting on specialized applications like its NeuraWave reservoir computer to carve out a niche in the artificial intelligence hardware market. Success depends on its ability to move from prototype development to higher-volume commercial manufacturing.
Investment Considerations for 2026
Choosing between these two stocks requires a trade-off between growth scale and risk. IonQ’s momentum is evident in its Q2 2026 performance, where it reported $80.1 million in sales, representing a 287% year-over-year increase. The firm raised its full-year outlook to between $280 million and $290 million. A $28 million contract extension with DARPA for quantum-based atomic clocks provides further validation of its technology.
QCi also reported recent growth, with $5.6 million in Q2 sales—a figure that topped its total revenue for all of 2025. Still, the valuation gap remains significant. IonQ trades at a price-to-sales (P/S) ratio of 62.3x, while QCi commands a P/S ratio of 188.4x. Given the current trajectory of record revenue quarters and the scale of its government contracts, IonQ presents a more grounded case for investors seeking exposure to the growth of the quantum sector as it stands in late 2026.